Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

October 15, 2026

Study Completion Date

October 15, 2026

Conditions
Trichotillomania (Hair-Pulling Disorder)
Interventions
DRUG

Valbenazine Oral Capsule

Participants randomized to active treatment will be given a starting dose of 40mg of valbenazine , which may be escalated to 80mg to achieve an optimal dose of the medication for each subject.

OTHER

Placebo Oral capsule

Participants randomized to placebo will be given a capsule that is the same shape and color as the active medication and will subject to the same dose escalation requirements as the other arm but will receive placebo during the treatment period.

Trial Locations (1)

06520

RECRUITING

Yale Child Study Center, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Neurocrine Biosciences

INDUSTRY

lead

Yale University

OTHER